NLVP
New Leaf Venture Partners Portfolio holdings
AUM
$52.9M
This Quarter Return
+17.83%
1 Year Return
-33.65%
3 Year Return
+15.24%
5 Year Return
+39.89%
10 Year Return
+615.06%
AUM
$114M
AUM Growth
+$114M
(-8%)
Cap. Flow
-$21.1M
Cap. Flow
% of AUM
-18.5%
Top 10 Holdings %
Top 10 Hldgs %
99.87%
Holding
12
New
–
Increased
–
Reduced
–
Closed
1
Top Buys
No buys this quarter
Top Sells
| 1 |
HARP
Harpoon Therapeutics, Inc. Common Stock
HARP
|
$21.1M |
Sector Composition
| 1 | Healthcare | 100% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
Arvinas
ARVN
$568M
| $53.2M | 46.59% | 1,289,521 | – | – |
|
2
Edgewise Therapeutics
EWTX
$1.51B
| $28.3M | 24.8% | 1,553,661 | – | – |
|
|
DCPH
3
DELISTED
Deciphera Pharmaceuticals, Inc. Common Stock
DCPH
| $9.08M | 7.94% | 576,975 | – | – |
|
4
Crinetics Pharmaceuticals
CRNX
$2.92B
| $6.6M | 5.78% | 141,000 | – | – |
|
5
Rallybio
RLYB
$22.4M
| $6.11M | 5.35% | 3,301,603 | – | – |
|
6
Passage Bio
PASG
$22.7M
| $3.37M | 2.95% | 2,497,922 | – | – |
|
7
Rocket Pharmaceuticals
RCKT
$354M
| $3.19M | 2.79% | 118,242 | – | – |
|
8
Alector
ALEC
$238M
| $2.04M | 1.79% | 339,569 | – | – |
|
9
Cogent Biosciences
COGT
$1.69B
| $1.69M | 1.47% | 250,765 | – | – |
|
10
X4 Pharmaceuticals
XFOR
$84.2M
| $466K | 0.41% | 335,000 | – | – |
|
11
Iterum Therapeutics
ITRM
$30.2M
| $150K | 0.13% | 97,084 | – | – |
|
|
HARP
12
DELISTED
Harpoon Therapeutics, Inc. Common Stock
HARP
| – | – | -1,859,168 | Closed | -$21.1M |
|